(10-1+10-2)–11-1
(10-1+10-2)+11-1
(10-1+10-2)–11-1
(10-1+10-2)+11-1
ln{(1–conversion) 1–
ln{(1–conversion) 1+
}
}
푘푚
푘푛
=
4
Tetrahedron Letters
Asada, S.; Kigoshi, H.; Uesugi, M. J. Am. Chem. Soc. 2004, 126,
3461–3471; (f) Sato, S.; Watanabe, M.; Katsuda, Y.; Murata, A.;
Wang, D. O., Uesugi, M. Angew. Chem. Int. Ed. 2015, 54, 1855–
1858.
Acknowledgments
This research was financially supported by Grants-in-Aids for
Scientific Research (S) (JP26221301), Young Scientists (B)
(JP15K18827, 16K17903), and Scientific Research on Innovative
Areas
Organocatalysts’ (JP23105008) and ‘Middle Molecular Strategy’
(JP16H01148).
2.
3.
4.
Bender, J. A.; Meanwell, N. A.; Wang, T. Tetrahedron 2002, 58,
3111–3128.
Jacobson, A. R.; Makris, A. N.; Sayre, L. M. J. Org. Chem. 1987,
52, 2592–2594.
(a) Stoutland, O.; Helgen, L.; Agre, C. L. J. Org. Chem. 1959, 24,
818–820; (b) Stahl, G. L.; Walter, R.; Smith, C. W. J. Org. Chem.
1978, 43, 2285–2286; (c) Bergeron, J. R.; Garlich, J. R.;
Stolowich, N. J. J. Org. Chem. 1984, 49, 2997–3001.
Wang, T.; Zhang, Z.; Meanwell, N. A. J. Org. Chem. 1999, 64,
7661–7662.
(a) Ham, J.-Y.; Kang, H.-S.; Bull. Korean Chem. Soc. 1994, 15,
1025–1027; (b) Zhang, Z.; Yin, Z.; Meanwell, N. A.; Kadow, J.
F.; Wang, T. Org. Lett. 2003, 5, 3399–3402.
‘Advanced
Molecular
Transformations
by
5.
6.
Table 3. Competitive acylation between 10 and its analogues
catalyzed by either 6 or DMAP.a
7.
(a) Atwell, G. J.; Denny, W. A. Synthesis 1984, 1032–1033; (b)
Verma, S. K.; Acharya, B. N.; Kaushik, M. P. Org. Lett. 2010, 12,
4232–4235.
8.
9.
Ueda, Y.; Kawabata, T. Top. Curr. Chem. 2016, 372, 203–231;
and references cited therein.
(a) Yoshida, K.; Furuta, T.; Kawabata, T. Angew. Chem. Int. Ed.
2011, 50, 4888–4892; (b) Imayoshi, A.; Yamanaka, M.; Sato, M.;
Yoshida, K.; Furuta, T.; Ueda, Y.; Kawabata, T. Adv. Synth.
Catal. 2016, 358, 1337–1344.
10. Acylation of free 1,5-diaminopentane was found to produce the
corresponding diacylate as the major product even in the presence
of the catalysts described in Table 1.
b
Entry
11
Catalyst
DMAP
6
10/10-1/10-2/11/11-1
25 : 55 : 13 : 82 : 12
1 : 96 : 1 : 97 : 1
k10/k11
11. (a) Yoshida, K.; Mishiro, K.; Ueda, Y.; Shigeta, T.; Furuta, T.;
Kawabata, T. Adv. Synth. Catal. 2012, 354, 3291–3298; (b)
Yamanaka, M.; Yoshida, U.; Sato, M.; Shigeta, T.; Yoshida, K.;
Furuta, T.; Kawabata, T. J. Org. Chem. 2015, 80, 3075–3082.
12. (a) Hasegawa, T.; Yamamoto, H. Bull. Chem. Soc. Jpn. 2000, 73,
423–428; (b) Banwell, M. G.; Crasto, C. F.; Easton, C. J.; Forrest,
A. K.; Karoli, T.; March, D. R.; Mensah, L.; Nairn, M. R.;
O’Hanlon, P. J.; Oldham, M. D.; Yue, W. Bioorg. Med. Chem.
Lett. 2000, 10, 2263–2266; (c) Wang, Y.; Soper, D. L.; Dirr, M. J.;
Delong, M. A.; De, B.; Wos, J. A. Chem. Pharm. Bull. 2000, 48,
1332–1337; (d) Yates, M. H.; Kallman, N. J.; Ley, C. P.; Wei, J.
N. Org. Process Res. Dev. 2009, 13, 255–262.
1
2
3
4
11a (R=H)
19
11a (R=H)
142
11b (R=NMeTs)
DMAP
32 : 45 : 17 : 73 : 19
6.4
11b (R=NMeTs)
6
2 : 93 : 1 : 94 : 2
63
a Run at the substrate concentration of 0.05 M based on the total amount of
the two sulfonamides.
b Determined by the following equation. Conversion was calculated from the
total amount of the recovery of the two disulfonamides.
Supplementary Material
Supplementary material that may be helpful in the review
process should be prepared and provided as a separate electronic
file. That file can then be transformed into PDF format and
submitted along with the manuscript and graphic files to the
appropriate editorial office.
References and notes
1.
For examples, (a) Walsh, D. A.; Green, J. B.; Franzyshen, S. K.;
Nolan, J. C.; Yanni, J. M. J. Med. Chem. 1991, 34, 927–934; (b)
Fukushi, H.; Mabuchi, H.; Terashita, Z.-I.; Nishikawa, K.;
Sugihara, H. Chem. Pharm. Bull. 1994, 42, 551–559; (c) Leonardi,
A.; Motta, G.; Boi, C.; Testa, R.; Poggesi, E.; De Benedetti, G.;
Menziani, M. C. J. Med. Chem. 1999, 42, 427–437; (d) Asada, S.;
Choi, Y.; Uesugi, M. J. Am. Chem. Soc. 2003, 125, 4992–4993;
(e) Shimogawa, H.; Kwon, Y.; Mao, Q.; Kawazoe, Y.; Choi, Y.;